Hydrogel migraine caps tied to fatal acrylamide toxicosis in dogs

A new JAVMA report is putting a sharper clinical frame around a poisoning signal that veterinary toxicologists have been tracking for months: dogs that chew open hydrogel migraine caps, eye masks, and similar wraps can develop acute, sometimes fatal, acrylamide toxicosis. The case series, led by ASPCA Poison Control investigators, identified 45 dogs with suspected exposure-related illness from consumer polyacrylamide-based products, with vomiting and severe neurologic signs among the most prominent features. Among 21 dogs with known outcomes, 14 died or were euthanized. (pubmed.ncbi.nlm.nih.gov)

This report builds on earlier warnings from both ASPCA and Pet Poison Helpline. In March 2026, a letter to the editor from Pet Poison Helpline authors flagged migraine caps containing hydrogel as a novel acrylamide source after dogs developed life-threatening neurologic signs within hours of ingestion. A separate three-dog case series published in August 2026 described fatal exposures linked to cooling masks and found acrylamide levels in tested products that far exceeded acceptable concentrations for regulated polyacrylamide materials. (ijclinmedcasereports.com)

The newer JAVMA series is larger and gives clinicians a better sense of the syndrome. According to the abstract indexed by PubMed, common signs included vomiting, tachycardia, seizures, ataxia, tremors, anxiety, agitation, frantic behavior, restlessness, aggression, panting, hyperthermia, hyperesthesia, hypotension, and lethargy or depression. In one dog, behavior consistent with hallucinations was reported. The most common clinicopathologic abnormalities were hypokalemia, hyperglycemia, and hemoconcentration. Management was supportive, typically using anticonvulsants, muscle relaxants, IV fluids, and electrolyte supplementation. (pubmed.ncbi.nlm.nih.gov)

Testing of implicated products is a key part of why this signal is getting attention. ASPCA said analyzed cooling gel products contained acrylamide concentrations from 12,900 to 51,800 ppm, which it described as 21 to 86 times the upper end of expected levels and thousands of times higher than specifications cited for certain medical-device-grade materials. Earlier published testing from related reports found lower but still striking concentrations, including 3,600 to 13,000 ppm in several hydrogel samples. Across reports, the toxicologic concern is the residual acrylamide monomer left after incomplete polymerization or released as the gel destabilizes, rather than the polyacrylamide polymer itself. (aspca.org)

Industry and expert reaction has been consistent: awareness is lagging behind the risk. ASPCA said its poison control team is now seeing severe cases weekly. AAHA, citing study author Renee Schmid, DVM, DABT, DABVT, reported that additional cases have been recognized beyond the initial published dogs and emphasized that even a relatively small amount of ingested gel may be enough to cause toxicosis. ASPCA’s professional guidance also notes that packaging may describe these gels as “nontoxic” or “medical grade,” language that could reassure pet parents without addressing the specific hazard posed by residual acrylamide. (aspca.org)

Why it matters: For veterinary professionals, this is exactly the kind of consumer-product exposure that can be missed on history unless teams ask specifically about migraine caps, eye masks, cooling wraps, pet cooling pads, or torn gel-filled products in the home. The reported onset can be rapid, the neurologic signs dramatic, and the fatality rate high in known-outcome cases. That has implications for triage, client communication, and discharge counseling, especially in ER and urgent care settings where unexplained tremors, seizures, ataxia, or agitation may initially suggest more familiar toxicants. (pubmed.ncbi.nlm.nih.gov)

The findings also widen the safety conversation beyond products made specifically for pets. Human headache-relief items stored in freezers, refrigerators, or bedside drawers may be just as relevant to a canine exposure history as a pet cooling mat. For general practice teams, this creates an opening for preventive education during routine visits, particularly for households with young, destructive, or indiscriminate chewers. For toxicology and emergency clinicians, it underscores the value of saving packaging, identifying the exact product, and consulting poison control early because treatment remains supportive and time-sensitive. (aaha.org)

What to watch: The next phase will likely include more formal clinical guidance, additional product testing across brands, and possible consumer-safety attention if regulators or manufacturers move toward warnings, reformulation, or recalls; as of the sources reviewed here, I did not find a specific CPSC or FDA recall tied to these hydrogel migraine products. (cpsc.gov)